Academy IRIS

Academy IRIS This retrospective analysis included eyes implanted with 1 of 2 IOL brands, with ≥365 days of follow-up available in the IRIS Registry, and ≥2 visits within 180 days of surgery. Analyses included Nd:YAG incidence due to PCO within 1 year after surgery by IOL type and brand, mean time to PCO diagnosis, and mean time to Nd:YAG. Of 89,947 eyes after cataract surgery, 24,834 (28%) had PCO diagnosis within 365 days, and 9262 (10%) underwent Nd:YAG; 4.1% of 57,523 eyes with monofocal and 21.2% of 32,424 eyes with diffractive multifocal (MF) or diffractive extended depth of focus (EDOF) IOLs had Nd:YAG. Nd:YAG was 3.2 times more likely in eyes with diffractive MF or diffractive EDOF IOLs versus monofocal. For monofocal IOLs, 3.2% of eyes with AcrySof Real-world data for AcrySof and Tecnis IOLs revealed lower Nd:YAG rates and longer time to PCO diagnosis and Nd:YAG after monofocal versus diffractive multifocal or diffractive EDOF implantation. Nd:YAG rates were significantly lower with AcrySof versus Tecnis IOLs.

Informations de copyright

© 2022 Horn et al.

Déclaration de conflit d'intérêts

JDH is a consultant and clinical investigator for Alcon Vision LLC, has received speaker fees from Alcon, and is a clinical investigator for Bausch & Lomb. BLF is a consultant for Alcon, AcuFocus, CorneaGen, and Imprimis Pharmaceuticals and a Medical Monitor for Ziemer NA. DT reports personal fees for medical monitor from Rayner; grants from Glaukos, Sight Sciences, and Alcon, outside the submitted work. HF is an employee of Verana Health, which was contracted by Alcon Vision LLC to conduct this study. MM and XG are employees of Alcon Vision LLC. The authors report no other conflicts of interest in this work.